Genetic variants in the PI3K/PTEN/AKT/mTOR pathway predict head and neck cancer patient second primary tumor/recurrence risk and response to retinoid chemoprevention.
about
Sirolimus and Everolimus Pathway: Reviewing Candidate Genes Influencing Their Intracellular EffectsSystems biology of cisplatin resistance: past, present and futureLow-level laser therapy can produce increased aggressiveness of dysplastic and oral cancer cell lines by modulation of Akt/mTOR signaling pathwayAssociation of mTOR polymorphisms with cancer risk and clinical outcomes: a meta-analysis.Genetic variations in the PI3K-PTEN-AKT-mTOR pathway are associated with distant metastasis in nasopharyngeal carcinoma patients treated with intensity-modulated radiation therapy.Retinoid Chemoprevention: Who Can Benefit?An endothelial TLR4-VEGFR2 pathway mediates lung protection against oxidant-induced injuryRetinoids and rexinoids in cancer prevention: from laboratory to clinic.GSTM1 copy number and promoter haplotype as predictors for risk of recurrence and/or second primary tumor in patients with head and neck cancer.Headway and hurdles in the clinical development of dietary phytochemicals for cancer therapy and prevention: lessons learned from vitamin A derivatives.Chemoprevention of head and neck squamous cell carcinoma through inhibition of NF-κB signaling.Targeting EGFR-PI3K-AKT-mTOR signaling enhances radiosensitivity in head and neck squamous cell carcinoma.A GG allele of 3'-side AKT1 SNP is associated with decreased AKT1 activation and better prognosis of gastric cancer.Negative human papillomavirus status and excessive alcohol consumption are significant risk factors for second primary malignancies in Japanese patients with oropharyngeal carcinoma.Phosphorylation of AKT(Ser473) serves as an independent prognostic marker for radiosensitivity in advanced head and neck squamous cell carcinoma.Estimate of the accelerated proliferation by protein tyrosine phosphatase (PTEN) over expression in postoperative radiotherapy of head and neck squamous cell carcinoma.Genetic variations in the PI3K/PTEN/AKT/mTOR pathway predict tumor response and disease-free survival in locally advanced rectal cancer patients receiving preoperative chemoradiotherapy and radical surgery.Association of the upregulated expression of focal adhesion kinase with poor prognosis and tumor dissemination in hypopharyngeal cancer.PI3K/PTEN/AKT/mTOR polymorphisms: association with clinical outcome in patients with head and neck squamous cell carcinoma receiving cetuximab-docetaxel.
P2860
Q26749011-3E3038B9-85B3-4AEB-A715-814A1C93BA6FQ26863585-A5B6935E-E89E-4403-9E52-335A1B313CE6Q34647479-1A4F4D1A-2D6C-4B35-8831-08A5B1F657A1Q35166585-F0E6C03D-854B-4209-B22F-1326C1F2B1E3Q36201710-276EF317-3DBC-4FB8-A62B-42EEFFF25DD8Q36236984-0CF7755C-09B7-4E08-B743-AAF888583DBFQ36570882-50053B47-4984-4887-A2F3-6186567DA83FQ36680198-8DD1FCB0-81D9-4332-BD9D-2D6E23604DD6Q36680283-51EA022E-5EF5-4220-A1C3-EFA927B092F9Q37601036-46E1CC8B-1E5D-4A5E-963A-86DB5F4CCEC4Q37728618-26250BC3-4B1D-461B-BF8D-B54B2BA1296AQ38344592-A61BD782-19CA-42C8-9003-866E7F554240Q42224250-51E659D7-29FB-437E-828D-E9673F230D6FQ42224729-0FE6CA1F-3DC9-4AE8-948E-95F71B17264DQ42468364-EDBAD9E3-DB8D-4717-8AEA-29A1A6C6D6ACQ51249729-2EBB807D-4EFC-4759-8199-0AD9CBDB7546Q52629228-0DEE5652-E9FC-4DBC-AB66-7473112C8511Q53126273-277F8807-0AE3-4D9B-BFEE-F8204798494AQ54227938-0D603F41-BF25-4340-875D-F625225F5AB8
P2860
Genetic variants in the PI3K/PTEN/AKT/mTOR pathway predict head and neck cancer patient second primary tumor/recurrence risk and response to retinoid chemoprevention.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Genetic variants in the PI3K/P ...... e to retinoid chemoprevention.
@ast
Genetic variants in the PI3K/P ...... e to retinoid chemoprevention.
@en
type
label
Genetic variants in the PI3K/P ...... e to retinoid chemoprevention.
@ast
Genetic variants in the PI3K/P ...... e to retinoid chemoprevention.
@en
prefLabel
Genetic variants in the PI3K/P ...... e to retinoid chemoprevention.
@ast
Genetic variants in the PI3K/P ...... e to retinoid chemoprevention.
@en
P2093
P2860
P1476
Genetic variants in the PI3K/P ...... e to retinoid chemoprevention.
@en
P2093
Carol J Etzel
Edward Kim
Fadlo R Khuri
J Jack Lee
Margaret R Spitz
Michelle A T Hildebrandt
Scott M Lippman
Waun Ki Hong
P2860
P304
P356
10.1158/1078-0432.CCR-11-3271
P407
P50
P577
2012-05-10T00:00:00Z